A high serum bFGF concentration was a favorable prognostic factor among patients with canonical (HR 3.88, 95% CI 1.06–14.2, log-rank test: p = 0.027, Supplementary Figure S1b) and metabolic (HR 5.31, 95% CI 1.15–24.6, log-rank test: p = 0.017, Supplementary Figure S1c) tumor phenotypes. The gene discussed is FGF2; the disease is neoplasm.